• Winter 2024 HRSA Update
• Winter 2024 Membership & Professional Standards Committee Update
• Winter 2024 OPTN Executive Update
• Winter 2024 OPTN Expeditious Task Force Regional Meeting Update

• Summer 2023 Membership & Professional Standards Committee Update
• Summer 2023 Member Quality Update
• Summer 2023 OPTN Executive Update
• Policy Oversight Committee

• Winter 2023 OPTN Executive Update
• Winter 2023 Membership & Professional Standards Committee Update
• Predictive Analytics

• OPTN Kidney & Pancreas Transplantation Committees
• OPTN Liver and Intestinal Organ Transplantation Committee
• OPTN Lung Transplantation Committee
• Membership & Professional Standards Committee

• OPTN Leadership Update
• Policy Oversight Committee
• Liver and Intestinal Organ Transplantation Committee

• Require Lower Respiratory SARS-CoV-2 Testing for Lung Donors
• Update Data Collection to Align with US Public Health Service Guideline 2020
• Guidance for Data Collection Regarding Classification of Citizenship Status
• Ethical Considerations of Continuous Distribution in Organ Allocation
• Update on OPTN Regional Review Project
• Report Primary Graft Dysfunction in Heart Transplant Recipients
• Amend Status Extension Requirements in Adult Heart Allocation Policy
• Update Human Leukocyte Antigen (HLA) Equivalency Tables
• Update on Continuous Distribution of Kidneys and Pancreata
• Review of National Liver Review Board (NLRB) Diagnoses and Update to Alcohol-Associated Diagnoses
• Establish Continuous Distribution of Lungs
• Reassess Inclusion of Race in Estimated Glomerular Filtration Rate (eGFR) Equation
• Enhance Transplant Program Performance Monitoring System
• Data Collection to Evaluate Organ Logistics and Allocation
• Establish Membership Requirements for Uterus Transplant Programs
• Refine Lung Data Fields

• OPTN Policy Oversight Committee
• OPTN Kidney and Pancreas Transplantation Committees
• OPTN Leadership Update

• Clarify Multi-Organ Allocation Policy
• Modify the Deceased Donor Registration (DDR) Form
• Develop Measures for Primary Graft Dysfunction in Hearts
• Update Transplant Program Key Personnel Training and Experience Requirements
• Calculate Median MELD at Transplant around the Donor Hospital and Update Sorting within Liver Allocation
• 2021-2024 OPTN Strategic Plan
• Require Notification of Human Leukocyte Antigen (HLA) Typing Changes
• Update National Liver Review Board Guidance Documents and Policy Clarification
• Revise General Considerations In Assessment for Transplant Candidacy

• Align OPTN Policy with U.S. Public Health Service Guideline, 2020
• Executive Update
• Kidney and Pancreas Transplantation Committees
• Liver and Intestinal Organ Transplantation Committee
• Lung Transplantation Committee
• Performance and Member Collaborative Projects
• SRTR Living Donor Collective Update
• The Future State of Organ Allocation

• Align OPTN Policy with U.S. Public Health Service Guideline, 2020
• Guidance and Policy Clarifications Addressing Adult Heart Allocation Policy
• Guidance Addressing the Use of Pediatric Heart Exceptions
• Modify Living Donor Policy to Include Living VCA Donors
• Further Enhancements to the National Liver Review Board (NLRB)
• Programming VCA Allocation in UNet
• Modify Data Collection on VCA Living Donors
• COVID-19 Emergency Policies and Data Collection
• Updated Cohort for Calculation of the Lung Allocation Score (LAS)
• Update on the Continuous Distribution of Organs Project
• COVID-19 Emergency Policies and Data Collection
• OPTN Public Comment Orientation

• Executive Update
• Membership & Professional Standards Committee
• Liver & Intestinal Organ Transplantation Committee
• Kidney Transplantation Committee
• Policy Oversight Committee
• 2020 OPTN Regional Review

• National Heart Review Board for Pediatrics (Thoracic Organ Transplantation Committee)
• Data Collection to Assess Socioeconomic Status (SES) and Access to Transplant (Minority Affairs Committee)
• Addressing Medically Urgent Candidates in New Kidney Allocation Policy (Kidney Transplantation Committee)
• Distribution of Kidneys and Pancreata from Alaska (Kidney & Pancreas Transplantation Committees)
• Modifications to Released Kidney and Pancreas Allocation (Organ Procurement Organization Committee)
• Enhancements to the National Liver Review Board (Liver and Intestinal Organ Transplantation Committee)
• Human Leukocyte Antigen (HLA) Equivalency Tables Update (2020) (Histocompatibility Committee)
• Guidance and Policy Modifications Addressing Blood Type Determination (Operations and Safety Committee)
  • Modify Blood Type Determination and Reporting Policies
  • Guidance on Blood Type Determination
• Update to VCA Transplant Outcomes Data Collection (Vascularized Composite Allograft (VCA) Transplantation Committee)
• Measuring Transplant Outcomes by Collecting Data on Children Born to Uterus Recipients (Vascularized Composite Allograft (VCA) Transplantation Committee)

Abdominal

• Addressing Medically Urgent Candidates in New Kidney Allocation Policy (Kidney Transplantation Committee)
• Modifications to Release Kidney and Pancreas Allocation (Organ Procurement Organization Committee)
• Enhancements to the National Liver Review Board (Liver and Intestinal Organ Transplantation Committee)
• Liver and Intestinal Transplantation Committee Update

Thoracic

• Thoracic Organ Transplantation Committee
  • Thoracic Organ Transplantation Committee Update
  • National Heart Review Board for Pediatrics
  • Continuous Distribution of Lungs Update

• Membership and Professional Standards Committee
• Policy Oversight Committee
• UNOS Member Quality Department
• Histocompatibility Committee
• Vascularized Composite Allograft (VCA) Transplantation Committee
• Transplant Coordinators Committee

• Winter 2020 OPTN Region Updates (PDF - 1478 K)
• Public Comment Proposals Winter 2020 (PDF; 1/2020; 4845 K)

Discussion agenda

• Modify Data Submission Policies, OPTN Data Advisory Committee
• Data Collection to Evaluate the Logistical Impact of Broader Distribution, OPTN Operations and Safety Committee
• Eliminate the Use of DSA and Region in Kidney Allocation Policy, OPTN Kidney Transplantation Committee
• Eliminate the Use of DSA and Region in Pancreas Allocation Policy, OPTN Pancreas Transplantation Committee
• Expedited Placement of Livers, OPTN Organ Procurement Organization Committee
• Continuous Distribution of Lungs Concept Paper, OPTN Thoracic Transplantation Committee

Non-discussion agenda

• Modify Appointment Process for Vice Chair, OPTN Histocompatibility Committee
• Clarification of Pre-Existing Liver Disease, OPTN Liver and Intestinal Organ Transplantation Committee

• Thoracic
• Pediatric
• Operations and Safety Committee
• Liver (All regions except Region 8)
• Liver (Region 8)

• National liver review board (NLRB) six-week report (PDF; 7/2019)